ADVM icon

Adverum Biotechnologies

92 hedge funds and large institutions have $85.9M invested in Adverum Biotechnologies in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 42 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

28% less capital invested

Capital invested by funds: $119M → $85.9M (-$33M)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

69% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 42

Holders
92
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.47M
Puts
$321K
Net Calls
Net Calls Change

Top Buyers

1 +$14.2M
2 +$724K
3 +$540K
4
Invesco
Invesco
Georgia
+$341K
5
BCM
Bridgeway Capital Management
Texas
+$317K

Top Sellers

1 -$9.6M
2 -$2.03M
3 -$1.71M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$928K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$519K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.2M
2
$9.58M
3
$9.11M
4
$8.58M
5
$6.64M
6
$4.63M
7
$3.93M
8
$3.49M
9
$2.3M
10
$2.21M
11
$2.06M
12
$1.97M
13
$1.87M
14
$1.87M
15
$1.37M
16
$1.3M
17
$994K
18
$778K
19
$659K
20
$519K
21
$519K
22
$518K
23
$508K
24
$469K
25
$426K